DEL-VI-A Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Del-vi-a, and when can generic versions of Del-vi-a launch?
Del-vi-a is a drug marketed by Del Ray Labs and is included in one NDA.
The generic ingredient in DEL-VI-A is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DEL-VI-A?
- What are the global sales for DEL-VI-A?
- What is Average Wholesale Price for DEL-VI-A?
Summary for DEL-VI-A
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 113 |
| Patent Applications: | 2,346 |
| DailyMed Link: | DEL-VI-A at DailyMed |
US Patents and Regulatory Information for DEL-VI-A
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Del Ray Labs | DEL-VI-A | vitamin a palmitate | CAPSULE;ORAL | 080830-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
